Non-small cell lung cancer (NSCLC) accounts for 85% of lung cancer cases worldwide and remains one of the deadliest cancers due to late detection and limited biomarkers. Researchers are increasingly looking at ion channels, especially the voltage-gated sodium channel subtype Nav1.7, as promising diagnostic markers.<\/p>\n
Nav<\/sub>1.7 is overexpressed in several cancers, including NSCLC, and has been linked to tumor cell migration, invasion, and proliferation. This makes it an attractive biomarker for cancer detection and aggressiveness assessment.<\/p>\n Huwentoxin-IV (HwTx-IV), a peptide derived from spider venom, is a well-characterized high-affinity inhibitor of Nav<\/sub>1.7. By attaching a Cy5 fluorophore to this peptide, researchers created Cy5-HwTx-IV, a probe that combines the natural selectivity of the toxin with the imaging capabilities of fluorescent label.<\/p>\n <\/p>\n Key findings:<\/strong><\/p>\n <\/p>\n These results establish Cy5-HwTx-IV as a powerful imaging tool for visualizing hNav<\/sub>1.7 in NSCLC, with potential for both preclinical diagnostics and future clinical translation. Beyond lung cancer, hNav<\/sub>1.7 overexpression in other tumor types suggests broader applications, possibly extending to PET imaging with radiolabeled derivatives.<\/p>\n Together, this work bridges toxin-based molecular imaging and cancer diagnostics, providing a new route to improve the precision of lung cancer detection.<\/p>\n __________<\/p>\n \ud83d\udcd6 Read the full article: Cyanine 5-huwentoxin-IV as a novel imaging probe to detect hNav1.7 channel overexpressed in non-small cell lung cancer (Biochemical Pharmacology, 2025)<\/a><\/p>\n\n